BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16620027)

  • 1. Structural aspects of interactions within the Myc/Max/Mad network.
    Nair SK; Burley SK
    Curr Top Microbiol Immunol; 2006; 302():123-43. PubMed ID: 16620027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mad side of the Max network: antagonizing the function of Myc and more.
    Rottmann S; Lüscher B
    Curr Top Microbiol Immunol; 2006; 302():63-122. PubMed ID: 16620026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermodynamics of protein-protein interactions of cMyc, Max, and Mad: effect of polyions on protein dimerization.
    Banerjee A; Hu J; Goss DJ
    Biochemistry; 2006 Feb; 45(7):2333-8. PubMed ID: 16475822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors.
    Nair SK; Burley SK
    Cell; 2003 Jan; 112(2):193-205. PubMed ID: 12553908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of the interaction of b/HLH/Z transcription factors Myc, Max, and Mad with cognate DNA.
    Ecevit O; Khan MA; Goss DJ
    Biochemistry; 2010 Mar; 49(12):2627-35. PubMed ID: 20170194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells.
    Grinberg AV; Hu CD; Kerppola TK
    Mol Cell Biol; 2004 May; 24(10):4294-308. PubMed ID: 15121849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mlx network: evidence for a parallel Max-like transcriptional network that regulates energy metabolism.
    Billin AN; Ayer DE
    Curr Top Microbiol Immunol; 2006; 302():255-78. PubMed ID: 16620032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and properties of a Myc derivative that efficiently homodimerizes.
    Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
    Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic in vivo interactions among Myc network members.
    Yin X; Landay MF; Han W; Levitan ES; Watkins SC; Levenson RM; Farkas DL; Prochownik EV
    Oncogene; 2001 Aug; 20(34):4650-64. PubMed ID: 11498788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule modulators of c-Myc/Max and Max/Max interactions.
    Berg T
    Curr Top Microbiol Immunol; 2011; 348():139-49. PubMed ID: 20680803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.
    Ayer DE; Kretzner L; Eisenman RN
    Cell; 1993 Jan; 72(2):211-22. PubMed ID: 8425218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes.
    Hurlin PJ; Ayer DE; Grandori C; Eisenman RN
    Cold Spring Harb Symp Quant Biol; 1994; 59():109-16. PubMed ID: 7587059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers.
    Maltais L; Montagne M; Bédard M; Tremblay C; Soucek L; Lavigne P
    PLoS One; 2017; 12(3):e0174413. PubMed ID: 28350847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Of Myc and Mnt.
    Hooker CW; Hurlin PJ
    J Cell Sci; 2006 Jan; 119(Pt 2):208-16. PubMed ID: 16410546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallization of a Complex Between MYC and Jas Motif.
    Zhang F; He SY; Melcher K
    Methods Mol Biol; 2020; 2085():133-144. PubMed ID: 31734922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New structural determinants for c-Myc specific heterodimerization with Max and development of a novel homodimeric c-Myc b-HLH-LZ.
    Beaulieu ME; McDuff FO; Frappier V; Montagne M; Naud JF; Lavigne P
    J Mol Recognit; 2012 Jul; 25(7):414-26. PubMed ID: 22733550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
    Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
    J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal Structures and Nuclear Magnetic Resonance Studies of the Apo Form of the c-MYC:MAX bHLHZip Complex Reveal a Helical Basic Region in the Absence of DNA.
    Sammak S; Hamdani N; Gorrec F; Allen MD; Freund SMV; Bycroft M; Zinzalla G
    Biochemistry; 2019 Jul; 58(29):3144-3154. PubMed ID: 31260268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.
    James L; Eisenman RN
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10429-34. PubMed ID: 12149476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription.
    Struntz NB; Chen A; Deutzmann A; Wilson RM; Stefan E; Evans HL; Ramirez MA; Liang T; Caballero F; Wildschut MHE; Neel DV; Freeman DB; Pop MS; McConkey M; Muller S; Curtin BH; Tseng H; Frombach KR; Butty VL; Levine SS; Feau C; Elmiligy S; Hong JA; Lewis TA; Vetere A; Clemons PA; Malstrom SE; Ebert BL; Lin CY; Felsher DW; Koehler AN
    Cell Chem Biol; 2019 May; 26(5):711-723.e14. PubMed ID: 30880155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.